Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Summer;13(3):1105-9.

"Budget impact analyses": a practical policy making tool for drug reimbursement decisions

Hamid Reza Jamshidi  1 , Naghmeh Foroutan  1 , Jamshid Salamzadeh  1
Affiliations

"Budget impact analyses": a practical policy making tool for drug reimbursement decisions

Hamid Reza Jamshidi et al. Iran J Pharm Res. 2014 Summer.

Abstract

In the present article, Budget Impact Analysis as an effective, practical financial tool has been introduced to the policy makers for improving drug formulary and reimbursement decision making. In Iran, Ministry of Health (MOH), health insurance organizations, and health care providers such as hospitals could take the most advantage of the BIAs reports.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Health care out-of-pocket expenditure in three countries; Iran, Pakistan, Turkey (21).
Figure 2
Figure 2
OOP payments in upper middle income countries (2011) (21).
See this image and copyright information in PMC

References

    1. Mauskopf J, Sullivan S, Annemans L, Caro J, Mullins C, Nuijten M, Orlewska E, Watkins J, Trueman P. Principles of good practice for budget impact analysis: report of the ispor task force on good research practices: budget impact analysis. Value in Health . 2007;10:336–347. - PubMed
    1. Sullivan SD, Mauskopf JA, Augustovski F, Caro J, Lee K, Minchin M, Orlewska E, Penna P, Rodriguez Barrios J, Shau W. Budget impact analysis- principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II task force. Value in Health . 2014;17:5–14. - PubMed
    1. Trueman P, Drummond MF, Hutton J. Developing guidance for budget impact analysis. Pharmacoeconomics . 2001;19:609–621. - PubMed
    1. Orlewska E, Gulacsi L. Budget-impact analyses: a critical review of published studies. Pharmacoeconomics . 2009;27:807–827. - PubMed
    1. Mauskopf J. Prevalence-based economic evaluation. Value in Health . 1998;1:251–259. - PubMed

LinkOut - more resources